Sponsors: []Modifications: Acetyl-alpha-methylfentanyl(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide),levo-(G)(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido) piperidine)(H)  Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);(J)(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide)(L), other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide(P)(Q)(R)(S)(T)(U)(V)(W)(X)(Y)(Z)(AA)(BB)(CC)(DD)(EE)(FF)(GG)(HH)(II)MPPP(1-methyl-4-phenyl-4-propionoxypiperidine)(JJ)(KK)(LL)(MM)(NN)(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]propanamide(OO)(PP)(QQ)(RR)(SS)(TT)(UU)(VV)(WW)(XX)(YY)(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide(ZZ)(AAA)(BBB), including the optical and geometric isomers(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and(CCC)  3-methylthiofentanyl(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).(2)(A)  Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;.-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;(B), some trade or other names:4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA(C)  4-bromo-2,5-dimethoxypenethylamine, some trade or other names:2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;(D), some trade or other names:2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA(E)  2,5-dimethoxy-4-ethylamphet-amine, some trade or other names: DOET;, some trade or other names:4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA(G)(H), some trade and other names:4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP"(I)(J)  3,4-methylenedioxymethamphetamine (MDMA);(K)  3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA,  MDE, MDEA;(L)  N-hydroxy-3,4-methylenedioxyamphetamine, also known asN-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;(M)(N), some trade and other names: 3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine(O), some trade and other names: N,N-Diethyltryptamine; DET(P), some trade or other names: DMT(Q), some trade and other names:7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino[5,4-b] indole; Tabernanthe iboga(R)(S)Marihuana;(T)(U), some trade or other names:3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl(V), meaning all parts of the plant presently classified botanically asLophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from anypart of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation ofsuch plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12))(W)(X)(Y)(Z)(AA), synthetic equivalents of the substances contained inthe plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,and their isomers with similar chemical structure and pharmacological activity such as thefollowing: .1 cis or trans tetrahydrocannabinol, and their optical isomers   .6 cis or transtetrahydrocannabinol, and their optical isomers .3,4 cis or trans tetrahydrocannabinol, and itsoptical isomers, and since nomenclature of these substances is not internationally standardized,compounds of these structures, regardless of numerical designation of atomic positions covered(BB), some trade or other names:N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE(CC), some trade or other names:1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP(DD), some trade or other names:1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and(EE)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.(A)  Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or4,5-dihydro-5-phenly-2-oxazolamine;(B)  Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;(C)(D)  Methcathinone, some other names: 2-(methylamino)-propiophenone;alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts ofoptical isomers;(E)  (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);(F); and(G)  N,N-dimethylamphetamine, also known as N,N-alpha-trimethyl-benzeneethanamine;N,N-alpha-trimethylphenethylamine(vi)  Any material, compound, mixture, or preparation which contains any quantity of thefollowing substances, including their optical isomers, salts, and salts of isomers, subject totemporary emergency scheduling:(A)  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and(B)  N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).nalmefene,and ecgoninetheir salts,, derivatives,and derivativesphenanthreneand levopropoxyphene(A)(B)(K),levo-(L)(Q)(R)(S)(T)(U)(V)(W)(X)(Y)(Z)  Remifentanil; and(B)(C)(D)(E)1-phenylcyclohexylamine(F)DronabinolU.S., someother names for dronabinol:(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or(-)-delta-9-(trans)-tetrahydrocannabinolNabilone, another name for nabilone:(.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one1308.32and(E)Chlorhexadol, some trade or other names for atiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,flupyrazapontheircalculated as the free anhydrous base or alkaloidpromotes muscle growth(A)  Boldenone;(B)  Chlorotestosterone (4-chlortestosterone);(C)(D)  Dehydrochlormethyltestosterone;(E)  Dihydrotestosterone (4-dihydrotestosterone);(F)  Drostanolone;(G)(H)  Fluoxymesterone;(I)  Formebulone (formebolone);(J)(K)  Methandienone;(L)  Methandranone;(M)  Methandriol;(N)(O)(P)(Q)  Mibolerone;(R)(S)(T)(U)(V)(W)  Stanolone;(X)(Y)  Testolactone;(Z); and(AA)  Trenbolone.Secretary of Health andHuman Services(D)  Butorphanol;(E)(F)(G)(H)(I)(J)(K)(L)(M)(N)(O)(P)(Q)(R)(S)(T)(U)(V)(W)(X)(Y)(Z)(AA)(BB)  Lormetazepam;(CC)(DD)(FF)(GG)(HH)  Midazolam;(II)  Nimetazepam;(JJ)(KK)(LL)(MM)(NN)(OO)(PP)(QQ)(RR)  Pinazepam;(SS)(TT)(UU)  Temazepam;(VV)(WW)  Triazolam; and(XX)  Zolpidem.((+)-norpseudoephedrine)Mazindol(G)(H)((-)-1-dimethylamino-1,2-diphenylethane)theircalculated as the free anhydrousbase or alkaloid; and(viii)  unless specifically excepted or unless listed in another schedule, any material,compound, mixture, or preparation containing any Buprenorphine and its salts.The symbols used in this bill do not appear in the electronic version.  Please refer to thehard copy version on file with the Utah House of Representatives or the Office of LegislativePrinting to view these symbols.Full text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

Download Zipped Introduced WP 6.1 HB0309.ZIP 20,965 Bytes
[Status][Bill Documents][Fiscal Note][Bills Directory]


H.B. 309





1     CONTROLLED SUBSTANCES ACT


2     AMENDMENTS




3    1998 GENERAL SESSION


4    STATE OF UTAH


5     Sponsor: Patrice Arent


6    AN ACT RELATING TO CONTROLLED SUBSTANCES; AMENDING THE CONTROLLED

7    SUBSTANCES ACT TO REFLECT THE FEDERAL CODE IN SCHEDULES I THROUGH

8    V; AND PROVIDING AN INFORMATIONAL NOTE.

9    This act affects sections of Utah Code Annotated 1953 as follows:

10    AMENDS:

11         58-37-4, as last amended by Chapter 64, Laws of Utah 1997

12    This act enacts uncodified material.

13    Be it enacted by the Legislature of the state of Utah:

14        Section 1.  Section  58-37-4 is amended to read:

15         58-37-4.  Schedules of controlled substances -- Schedules I through V -- Findings

16     required -- Specific substances included in schedules.

17        (1)  There are established five schedules of controlled substances known as Schedules I,

18    II, III, IV, and V which shall consist of substances listed in this section.

19        (2)  Schedules I, II, III, IV, and V consist of the following drugs or other substances by the

20    official name, common or usual name, chemical name, or brand name designated:

21        (a)  Schedule I:

22        (i)  Unless specifically excepted or unless listed in another schedule, any of the following

23    opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when

24    the existence of the isomers, esters, ethers, and salts is possible within the specific chemical

25    designation:

26        (A)  [Acetyl-alphamethylfentanyl] Acetyl-alpha-methylfentanyl

27    (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);


1        (B)  Acetylmethadol;

2        (C)  Allylprodine;

3        (D)  Alphacetylmethadol, [(]except levo-alphacetylmethadol also known as

4    levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM[)];

5        (E)  Alphameprodine;

6        (F)  Alphamethadol;

7        [(G)  Alpha-methiofentanyl;]

8        [(H)] (G)  Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]

9    propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido) piperidine);

10        (H)  Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-

11    piperidinyl]-N-phenylpropanamide);

12        (I)  Benzethidine;

13        [(L)] (J)  Betacetylmethadol;

14        (K)  Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-

15    piperidinyl]-N-phenylpropanamide);

16        [(J)] (L)  Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-

17    phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;

18        (M)  Betameprodine;

19        (N)  Betamethadol;

20        (O)  Betaprodine;

21        [(P)  Cathinone;]

22        [(Q)] (P)  Clonitazene;

23        [(R)] (Q)  Dextromoramide;

24        [(S)] (R)  Diampromide;

25        [(T)] (S)  Diethylthiambutene;

26        [(U)] (T)  Difenoxin;

27        [(V)] (U)  Dimenoxadol;

28        [(W)] (V)  Dimepheptanol;

29        [(X)] (W)  Dimethylthiambutene;

30        [(Y)] (X)  Dioxaphetyl butyrate;

31        [(Z)] (Y)  Dipipanone;

- 2 -


1        [(AA)] (Z)  Ethylmethylthiambutene;

2        [(BB)] (AA)  Etonitazene;

3        [(CC)] (BB)  Etoxeridine;

4        [(DD)] (CC)  Furethidine;

5        [(EE)] (DD)  Hydroxypethidine;

6        [(FF)] (EE)  Ketobemidone;

7        [(GG)] (FF)  Levomoramide;

8        [(HH)] (GG)  Levophenacylmorphan;

9        [(II)  Methcathinone;]

10        [(JJ)] (HH)  Morpheridine;

11        [(KK)] (II)  [Mppp (l-methyl-4-phenyl-4-propionoxpipiridine)] MPPP

12    (1-methyl-4-phenyl-4-propionoxypiperidine);

13        [(LL)] (JJ)  Noracymethadol;

14        [(MM)] (KK)  Norlevorphanol;

15        [(NN)] (LL)  Normethadone;

16        [(OO)] (MM)  Norpipanone;

17        [(PP)] (NN)  Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]

18    propanamide;

19        [(QQ)] (OO)  PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);

20        [(RR)] (PP)  Phenadoxone;

21        [(SS)] (QQ)  Phenampromide;

22        [(TT)] (RR)  Phenomorphan;

23        [(UU)] (SS)  Phenoperidine;

24        [(VV)] (TT)  Piritramide;

25        [(WW)] (UU)  Proheptazine;

26        [(XX)] (VV)  Properidine;

27        [(YY)] (WW)  Propiram;

28        [(ZZ)] (XX)  Racemoramide;

29        [(AAA)] (YY)  Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;

30        [(BBB)] (ZZ)  Tilidine;

31        [(CCC)] (AAA)  Trimeperidine;

- 3 -


1        [(DDD)  3-menthylthiofentanyl; and]

2        [(EEE)] (BBB)  3-methylfentanyl[.], including the optical and geometric isomers

3    (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and

4        (CCC)  3-methylthiofentanyl

5    (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).

6        (ii)  Unless specifically excepted or unless listed in another schedule, any of the following

7    opium derivatives, their salts, isomers, and salts of isomers when the existence of the salts,

8    isomers, and salts of isomers is possible within the specific chemical designation:

9        (A)  Acetorphine;

10        (B)  Acetyldihydrocodeine;

11        (C)  Benzylmorphine;

12        (D)  Codeine methylbromide;

13        (E)  Codeine-N-Oxide;

14        (F)  Cyprenorphine;

15        (G)  Desomorphine;

16        (H)  Dihydromorphine;

17        (I)  Drotebanol;

18        (J)  Etorphine (except hydrochloride salt);

19        (K)  Heroin;

20        (L)  Hydromorphinol;

21        (M)  Methyldesorphine;

22        (N)  Methylhydromorphine;

23        (O)  Morphine methylbromide;

24        (P)  Morphine methylsulfonate;

25        (Q)  Morphine-N-Oxide;

26        (R)  Myrophine;

27        (S)  Nicocodeine;

28        (T)  Nicomorphine;

29        (U)  Normorphine;

30        (V)  Pholcodine; and

31        (W)  Thebacon.

- 4 -


1        (iii)  Unless specifically excepted or unless listed in another schedule, any material,

2    compound, mixture, or preparation which contains any quantity of the following hallucinogenic

3    substances, or which contains any of their salts, isomers, and salts of isomers when the existence

4    of the salts, isomers, and salts of isomers is possible within the specific chemical designation; as

5    used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and geometric

6    isomers:

7        (A)  Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;

8    .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;

9        [(A)] (B)  4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:

10    4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;

11        (C)  4-bromo-2,5-dimethoxypenethylamine, some trade or other names:

12    2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;

13        [(B)] (D)  2,5-dimethoxyamphetamine, some trade or other names:

14    2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;

15        (E)  2,5-dimethoxy-4-ethylamphet-amine, some trade or other names: DOET;

16        (F)  4-methoxyamphetamine, some trade or other names:

17    4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;

18        [(E)] (G)  5-methoxy-3,4-methylenedioxy amphetamine;

19        [(K)] (H)  4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:

20    4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";

21        [(C)] (I)  3,4-methylenedioxy amphetamine;

22        [(D)  3,4-methylenedioxy methamphetamine (MDMA);]

23        (J)  3,4-methylenedioxymethamphetamine (MDMA);

24        (K)  3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-

25    alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA,  MDE, MDEA;

26        (L)  N-hydroxy-3,4-methylenedioxyamphetamine, also known as

27    N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;

28        [(G)] (M)  3,4,5-trimethoxy amphetamine;

29        [(H)] (N)  Bufotenine, some trade and other names: 3-(.

30    -Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,

31    N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;

- 5 -


1        [(I)] (O)  Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;

2        [(J)] (P)  Dimethyltryptamine, some trade or other names: DMT;

3        [(L)] (Q)  Ibogaine, some trade and other names:

4    7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino

5    [5,4-b] indole; Tabernanthe iboga;

6        [(M)] (R)  Lysergic acid diethylamide;

7        [(N)] (S)  [Marijuana] Marihuana;;

8        [(O)] (T)  Mescaline;

9        [(P)] (U)  Parahexyl, some trade or other names:

10    3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;

11        [(Q)] (V)  Peyote, meaning all parts of the plant presently classified botanically as

12    Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any

13    part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of

14    such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));

15        [(R)] (W)  N-ethyl-3-piperidyl benzilate;

16        [(S)] (X)  N-methyl-3-piperidyl benzilate;

17        [(T)] (Y)  Psilocybin;

18        [(U)] (Z)  Psilocyn;

19        [(V)] (AA)  Tetrahydrocannabinols, synthetic equivalents of the substances contained in

20    the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,

21    and their isomers with similar chemical structure and pharmacological activity such as the

22    following: .1 cis or trans tetrahydrocannabinol, and their optical isomers   .6 cis or trans

23    tetrahydrocannabinol, and their optical isomers .3,4 cis or trans tetrahydrocannabinol, and its

24    optical isomers, and since nomenclature of these substances is not internationally standardized,

25    compounds of these structures, regardless of numerical designation of atomic positions covered;

26        [(W)] (BB)  Ethylamine analog of phencyclidine, some trade or other names:

27    N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,

28    N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;

29        [(X)] (CC)  Pyrrolidine analog of phencyclidine, some trade or other names:

30    1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;

31        [(Y)  1-1-(2-Thieny) Cyclohexyl Pyrrolidine; and]

- 6 -


1        [(Z)] (DD)  Thiophene analog of phencyclidine[.], some trade or other names:

2    1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and

3        (EE)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.

4        (iv)  Unless specifically excepted or unless listed in another schedule, any material

5    compound, mixture, or preparation which contains any quantity of the following substances having

6    a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers

7    when the existence of the salts, isomers, and salts of isomers is possible within the specific

8    chemical designation:

9        (A)  Mecloqualone; and

10        (B)  Methaqualone.

11        (v)  Any material, compound, mixture, or preparation containing any quantity of the

12    following substances having a stimulant effect on the central nervous system, including their salts,

13    isomers, and salts of isomers:

14        (A)  Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or

15    4,5-dihydro-5-phenly-2-oxazolamine;

16        (B)  Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,

17    alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;

18        [(A)] (C)  Fenethylline;

19        (D)  Methcathinone, some other names: 2-(methylamino)-propiophenone;

20    alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;

21    alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;

22    methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of

23    optical isomers;

24        [(B)  4-Methylaminorex; and]

25        (E)  (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);

26        [(C)] (F)  N-ethylamphetamine; and

27        (G)  N,N-dimethylamphetamine, also known as N,N-alpha-trimethyl-benzeneethanamine;

28    N,N-alpha-trimethylphenethylamine.

29        (vi)  Any material, compound, mixture, or preparation which contains any quantity of the

30    following substances, including their optical isomers, salts, and salts of isomers, subject to

31    temporary emergency scheduling:

- 7 -


1        (A)  N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and

2        (B)  N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).

3        (b)  Schedule II:

4        (i)  Unless specifically excepted or unless listed in another schedule, any of the following

5    substances whether produced directly or indirectly by extraction from substances of vegetable

6    origin, or independently by means of chemical synthesis, or by a combination of extraction and

7    chemical synthesis:

8        (A)  Opium and opiate, and any salt, compound, derivative, or preparation of opium or

9    opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,

10    and their respective salts, but including:

11        (I)  Raw opium;

12        (II)  Opium extracts;

13        (III)  Opium fluid [extracts];

14        (IV)  Powdered opium;

15        (V)  Granulated opium;

16        (VI)  Tincture of opium;

17        (VII)  Codeine;

18        (VIII)  Ethylmorphine;

19        (IX)  Etorphine hydrochloride;

20        (X)  Hydrocodone;

21        (XI)  Hydromorphone;

22        (XII)  Metopon;

23        (XIII)  Morphine;

24        (XIV)  Oxycodone;

25        (XV)  Oxymorphone; and

26        (XVI)  Thebaine;

27        (B)  Any salt, compound, derivative, or preparation which is chemically equivalent or

28    identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these

29    substances may not include the isoquinoline alkaloids of opium;

30        (C)  Opium poppy and poppy straw;

31        (D)  Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any

- 8 -


1    salt, compound, derivative, or preparation which is chemically equivalent or identical with any of

2    these substances, and includes cocaine and ecgonine, [its] their salts, isomers, derivatives, and salts

3    of isomers and derivatives, whether derived from the coca plant or synthetically produced, except

4    the substances may not include decocainized coca leaves or extraction of coca leaves, which

5    extractions do not contain cocaine or ecgonine; and

6        (E)  Concentrate of poppy straw, which means the crude extract of poppy straw in either

7    liquid, solid, or powder form which contains the [phenanthrine] phenanthrene alkaloids of the

8    opium poppy.

9        (ii)  Unless specifically excepted or unless listed in another schedule, any of the following

10    opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when

11    the existence of the isomers, esters, ethers, and salts is possible within the specific chemical

12    designation, except dextrorphan and levopropoxyphene:

13        [(B)] (A)  Alfentanil;

14        [(A)] (B)  Alphaprodine;

15        (C)  Anileridine;

16        (D)  Bezitramide;

17        (E)  Bulk dextropropoxyphene (nondosage forms);

18        (F)  Carfentanil;

19        (G)  Dihydrocodeine;

20        (H)  Diphenoxylate;

21        (I)  Fentanyl;

22        (J)  Isomethadone;

23        [(L)] (K)  Levo-alphacetylmethadol, [(]some other names: levo-alpha-acetylmethadol,

24    levomethadyl acetate, or LAAM[)];

25        [(K)] (L)  Levomethorphan;

26        (M)  Levorphanol;

27        (N)  Metazocine;

28        (O)  Methadone;

29        (P)  Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;

30        [(Q)  Methyl-Fentanyl;]

31        [(R)] (Q)  Moramide-Intermediate, 2-methyl-3-morpholino-1,

- 9 -


1    1-diphenylpropane-carboxylic acid;

2        [(S)] (R)  Pethidine (meperidine);

3        [(T)] (S)  Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;

4        [(U)] (T)  Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;

5        [(V)] (U)  Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;

6        [(W)] (V)  Phenazocine;

7        [(X)] (W)  Piminodine;

8        [(Y)] (X)  Racemethorphan;

9        [(Z)] (Y)   Racemorphan; [and]

10        (Z)  Remifentanil; and

11        (AA)  Sufentanil.

12        (iii)  Unless specifically excepted or unless listed in another schedule, any material,

13    compound, mixture, or preparation which contains any quantity of the following substances having

14    a stimulant effect on the central nervous system:

15        (A)  Amphetamine, its salts, optical isomers, and salts of its optical isomers;

16        (B)  Methamphetamine, its salts, isomers, and salts of its isomers;

17        (C)  Phenmetrazine and its salts; and

18        (D)  Methylphenidate.

19        (iv)  Unless specifically excepted or unless listed in another schedule, any material,

20    compound, mixture, or preparation which contains any quantity of the following substances having

21    a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers

22    when the existence of the salts, isomers, and salts of isomers is possible within the specific

23    chemical designation:

24        (A)  Amobarbital;

25        [(B)  N,N,Dimethylamphetamine;]

26        [(C)] (B)  Glutethimide;

27        [(D)] (C)  Pentobarbital;

28        [(E)] (D)  Phencyclidine;

29        [(F)] (E)  Phencyclidine immediate precursors: [1-phenyl-cyclohexylamine]

30    1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile (PCC); and

31        [(G)] (F)  Secobarbital.

- 10 -


1        (v)  Unless specifically excepted or unless listed in another schedule, any material,

2    compound, mixture, or preparation which contains any quantity of Phenylacetone.

3        Some of these substances may be known by trade or other names: phenyl-2-propanone,

4    P2P; benzyl methyl ketone, methyl benzyl ketone.

5        (vi) (A)  [Dranabinol] Dronabinol (synthetic) in sesame oil and encapsulated in a soft

6    gelatin capsule in a [Fulnal] U.S. Food and Drug Administration approved drug product, some

7    other names for dronabinol:

8    (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or

9    (-)-delta-9-(trans)-tetrahydrocannabinol; and

10        (B)  [Nabinol] Nabilone, another name for nabilone:

11    (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,

12    6-dimethyl-9H-dibenzo[b,d]pyran-9-one.

13        (c)  Schedule III:

14        (i)  Unless specifically excepted or unless listed in another schedule, any material,

15    compound, mixture, or preparation which contains any quantity of the following substances having

16    a stimulant effect on the central nervous system, including its salts, isomers whether optical,

17    position, or geometric, and salts of the isomers when the existence of the salts, isomers, and salts

18    of isomers is possible within the specific chemical designation:

19        (A)  Those compounds, mixtures, or preparations in dosage unit form containing any

20    stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were listed

21    on August 25, 1971, as excepted compounds under Section [308.32] 1308.32 of Title 21 of the

22    Code of Federal Regulations, and any other drug of the quantitive composition shown in that list

23    for those drugs or which is the same except that it contains a lesser quantity of controlled

24    substances;

25        (B)  Benzphetamine;

26        (C)  Chlorphentermine;

27        (D)  Clortermine; and

28        [(E)  Mazindol; and]

29        [(F)] (E)  Phendimetrazine.

30        (ii)  Unless specifically excepted or unless listed in another schedule, any material,

31    compound, mixture, or preparation which contains any quantity of the following substances having

- 11 -


1    a depressant effect on the central nervous system:

2        (A)  Any compound, mixture, or preparation containing amobarbital, secobarbital,

3    pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients which

4    are not listed in any schedule;

5        (B)  Any suppository dosage form containing amobarbital, secobarbital, or pentobarbital,

6    or any salt of any of these drugs which is approved by the Food and Drug Administration for

7    marketing only as a suppository;

8        (C)  Any substance which contains any quantity of a derivative of barbituric acid or any

9    salt of any of them;

10        (D)  [Chorhexadol] Chlorhexadol;

11        (E)  Lysergic acid;

12        (F)  Lysergic acid amide;

13        (G)  Methyprylon;

14        (H)  Sulfondiethylmethane;

15        (I)  Sulfonethylmethane;

16        (J)  Sulfonmethane; and

17        (K)  Tiletamine and zolazepam or any of their salts, some trade or other names for a

18    tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine: 

19    2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam: 

20    4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,

21    flupyrazapon.

22        (iii)  Nalorphine.

23        (iv)  Unless specifically excepted or unless listed in another schedule, any material,

24    compound, mixture, or preparation containing limited quantities of any of the following narcotic

25    drugs, or [any] their salts [of any of them] calculated as the free anhydrous base or alkaloid:

26        (A)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams

27    per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;

28        (B)  Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams

29    per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic

30    amounts;

31        (C)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more

- 12 -


1    than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid

2    of opium;

3        (D)  Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more

4    than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in

5    recognized therapeutic amounts;

6        (E)  Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90

7    milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized

8    therapeutic amounts;

9        (F)  Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than

10    15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized

11    therapeutic amounts;

12        (G)  Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not

13    more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in

14    recognized therapeutic amounts;

15        (H)  Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with

16    one or more active, non-narcotic ingredients in recognized therapeutic amounts.

17        (v)  Unless specifically excepted or unless listed in another schedule, anabolic steroids

18    including any of the following or any isomer, ester, salt, or derivative of the following that [acts

19    in the same manner on the human body] promotes muscle growth:

20        (A)  Boldenone;

21        (B)  Chlorotestosterone (4-chlortestosterone);

22        [(A)] (C)  Clostebol;

23        [(B)  Chorionic gonadotropin;]

24        [(C)  Dehydroclormethyltestosterone;]

25        (D)  Dehydrochlormethyltestosterone;

26        (E)  Dihydrotestosterone (4-dihydrotestosterone);

27        (F)  Drostanolone;

28        [(D)] (G)  Ethylestrenol;

29        [(E)  Fluxymesterone;]

30        (H)  Fluoxymesterone;

31        (I)  Formebulone (formebolone);

- 13 -


1        [(F)] (J)  Mesterolone;

2        [(G)  Methandrenone;]

3        (K)  Methandienone;

4        (L)  Methandranone;

5        (M)  Methandriol;

6        [(H)] (N)  Methandrostenolone;

7        [(I)] (O)  Methenolone;

8        [(J)] (P)  Methyltestosterone[, except when combined with esterified estrogens];

9        (Q)  Mibolerone;

10        [(K)] (R)  Nandrolone [decanoate];

11        [(L)  Nandrolone phenpropionate;]

12        [(M)] (S)  Norethandrolone;

13        [(N)] (T)  Oxandrolone;

14        [(O)] (U)  Oxymesterone;

15        [(P)] (V)  Oxymetholone;

16        (W)  Stanolone;

17        [(Q)] (X)  Stanozolol; [and]

18        (Y)  Testolactone;

19        [(R)] (Z)  Testosterone [propionate.]; and

20        (AA)  Trenbolone.

21        Anabolic steroids expressly intended for administration through implants to cattle or other

22    nonhuman species, and approved by the [Food and Drug Administration] Secretary of Health and

23    Human Services for use, may not be classified as a controlled substance.

24        (d)  Schedule IV:

25        (i)  Unless specifically excepted or unless listed in another schedule, any material,

26    compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not less

27    than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them;

28        (ii)  Unless specifically excepted or unless listed in another schedule, any material,

29    compound, mixture, or preparation which contains any quantity of the following substances,

30    including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts

31    of isomers is possible within the specific chemical designation:

- 14 -


1        (A)  Alprazolam;

2        (B)  Barbital;

3        (C)  Bromazepam;

4        (D)  Butorphanol;

5        [(D)] (E)  Camazepam;

6        [(E)] (F)  Chloral betaine;

7        [(F)] (G)  Chloral hydrate;

8        [(G)] (H)  Chlordiazepoxide;

9        [(H)] (I)  Clobazam;

10        [(I)] (J)  Clonazepam;

11        [(J)] (K)  Clorazepate;

12        [(K)] (L)  Clotiazepam;

13        [(L)] (M)  Cloxazolam;

14        [(M)] (N)  Delorazepam;

15        [(N)] (O)  Diazepam;

16        [(O)] (P)  Estazolam;

17        [(P)] (Q)  Ethchlorvynol;

18        [(Q)] (R)  Ethinamate;

19        [(R)] (S)  Ethyl loflazepate;

20        [(S)] (T)  Fludiazepam;

21        [(T)] (U)  Flunitrazepam;

22        [(U)] (V)  Flurazepam;

23        [(V)] (W)  Halazepam;

24        [(W)] (X)  Haloxazolam;

25        [(X)] (Y)  Ketazolam;

26        [(Y)] (Z)  Loprazolam;

27        [(Z)] (AA)  Lorazepam;

28        (BB)  Lormetazepam;

29        [(AA)] (CC)  Mebutamate;

30        [(BB)] (DD)  Medazepam;

31        [(CC)  Medazolam;]

- 15 -


1        (EE)  Meprobamate;

2        [(DD)] (FF)  Methohexital;

3        [(FF)] (GG)  Methylphenobarbital (mephobarbital);

4        [(GG)  Nemetazepam;]

5        (HH)  Midazolam;

6        (II)  Nimetazepam;

7        [(HH)] (JJ)  Nitrazepam;

8        [(II)] (KK)  Nordiazepam;

9        [(JJ)] (LL)  Oxazepam;

10        [(KK)] (MM)  Oxazolam;

11        [(LL)] (NN)  Paraldehyde;

12        [(MM)  Penazepam;]

13        [(NN)] (OO)  Pentazocine;

14        [(OO)] (PP)  Petrichloral;

15        [(PP)] (QQ)  Phenobarbital;

16        (RR)  Pinazepam;

17        [(QQ)] (SS)  Prazepam;

18        [(RR)] (TT)  Quazepam;

19        [(SS)  Tempazepam;]

20        (UU)  Temazepam;

21        [(TT)] (VV)  Tetrazepam; [and]

22        [(UU)  Treazolam.]

23        (WW)  Triazolam; and

24        (XX)  Zolpidem.

25        (iii)  Any material, compound, mixture, or preparation of fenfluramine which contains any

26    quantity of the following substances, including its salts, isomers whether optical, position, or

27    geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers

28    is possible.

29        (iv)  Unless specifically excepted or unless listed in another schedule, any material,

30    compound, mixture, or preparation which contains any quantity of the following substances having

31    a stimulant effect on the central nervous system, including its salts, isomers whether optical,

- 16 -


1    position, or geometric isomers, and salts of the isomers when the existence of the salts, isomers,

2    and salts of isomers is possible within the specific chemical designation:

3        (A)  Cathine ((+)-norpseudoephedrine);

4        (B)  Diethylpropion;

5        (C)  Fencamfamine;

6        (D)  Fenproprex;

7        (E)  [Mazidole] Mazindol;

8        (F)  Mefenorex;

9        [(H)] (G)  Pemoline, including organometallic complexes and chelates thereof;

10        [(G)] (H)  Phentermine;

11        (I)  Pipradrol; and

12        (J)SPA[((-)-1-climethylamino-1,2 diphenylethane)]

13    ((-)-1-dimethylamino-1,2-diphenylethane).

14        (v)  Unless specifically excepted or unless listed in another schedule, any material,

15    compound, mixture, or preparation which contains any quantity of dextropropoxyphene

16    (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.

17        (e)  Schedule V: Any compound, mixture, or preparation containing any of the following

18    limited quantities of narcotic drugs, or their salts [of any of them] calculated as the free anhydrous

19    base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in

20    sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal

21    qualities other than those possessed by the narcotic drug alone:

22        (i)  not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;

23        (ii)  not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;

24        (iii)  not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;

25        (iv)  not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of

26    atropine sulfate per dosage unit;

27        (v)  not more than 100 milligrams of opium per 100 milliliters or per 100 grams;

28        (vi)  not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine

29    sulfate per dosage unit; [and]

30        (vii)  unless specifically exempted or excluded or unless listed in another schedule, any

31    material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant effect

- 17 -


1    on the central nervous system, including its salts, isomers, and salts of isomers[.]; and

2        (viii)  unless specifically excepted or unless listed in another schedule, any material,

3    compound, mixture, or preparation containing any Buprenorphine and its salts.

4        Section 2.   Informational note.

5        The symbols used in this bill do not appear in the electronic version.  Please refer to the

6    hard copy version on file with the Utah House of Representatives or the Office of Legislative

7    Printing to view these symbols.




 Legislative Review Note
    as of   1-23-98  12:13 PM


A limited legal review of this bill raises no obvious constitutional or statutory concerns.

 Office of Legislative Research and General Counsel


- 18 -
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







